Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
Study sponsor: SpyGlass Pharma, Inc. · SGP
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2029-03-31Estimated
Enrollment · participants400Estimated
Source updated2025-10-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.